Featured news
Blog
Announcement
science & technology
Xconomy
Asimov Announces Cell Line Development Partnership with Kaigene to Advance Multispecific Antibody for Autoimmune Disease
Blog
Announcement
science & technology
Forbes
Blog
Announcement
science & technology
Xconomy
Kyungdong Pharmaceutical and Asimov Announce Completion of Cell Line Development Campaign for Biosimilar Antibody
All news
Blog
announcement
science & technology
Asimov Announces Cell Line Development Partnership with Kaigene to Advance Multispecific Antibody for Autoimmune Disease
Asimov Announces Cell Line Development Partnership with Kaigene to Advance Multispecific Antibody for Autoimmune Disease
Asimov Announces Cell Line Development Partnership with Kaigene to Advance Multispecific Antibody for Autoimmune Disease
August 18, 2026
Blog
announcement
science & technology
Kyungdong Pharmaceutical and Asimov Announce Completion of Cell Line Development Campaign for Biosimilar Antibody
Kyungdong Pharmaceutical and Asimov Announce Completion of Cell Line Development Campaign for Biosimilar Antibody
Kyungdong Pharmaceutical and Asimov Announce Completion of Cell Line Development Campaign for Biosimilar Antibody
August 9, 2026
Blog
announcement
science & technology
Asimov Joins the Genesis Mission, Using Boston University's NSF-Backed Cloud Lab to Power Lab-in-the-Loop AI Models
Asimov Joins the Genesis Mission, Using Boston University's NSF-Backed Cloud Lab to Power Lab-in-the-Loop AI Models
Asimov Joins the Genesis Mission, Using Boston University's NSF-Backed Cloud Lab to Power Lab-in-the-Loop AI Models
July 24, 2026
Blog
announcement
science & technology
Asimov Launches Chrysalis Transposase, a Wholly-Owned Genome Integration Tool for Biotherapeutics Production
Asimov Launches Chrysalis Transposase, a Wholly-Owned Genome Integration Tool for Biotherapeutics Production
Asimov Launches Chrysalis Transposase, a Wholly-Owned Genome Integration Tool for Biotherapeutics Production
June 23, 2026
Blog
announcement
science & technology
Asimov Announces Strategic Partnership with the Rosalind & Morris Goodman Cancer Institute at McGill University to Advance Next-Generation Biologics
Asimov Announces Strategic Partnership with the Rosalind & Morris Goodman Cancer Institute at McGill University to Advance Next-Generation Biologics
Asimov Announces Strategic Partnership with the Rosalind & Morris Goodman Cancer Institute at McGill University to Advance Next-Generation Biologics
June 18, 2026
Blog
announcement
science & technology
Asimov Completes Lead Optimization Campaign with Mabylon AG to Advance Trispecific Antibody for Tree Pollen Allergies
Asimov Completes Lead Optimization Campaign with Mabylon AG to Advance Trispecific Antibody for Tree Pollen Allergies
Asimov Completes Lead Optimization Campaign with Mabylon AG to Advance Trispecific Antibody for Tree Pollen Allergies
May 7, 2026
Blog
announcement
science & technology
Asimov Launches RNA Edge, a Lab-in-the-Loop Platform for AI Optimization of RNA Therapeutic Candidates
Asimov Launches RNA Edge, a Lab-in-the-Loop Platform for AI Optimization of RNA Therapeutic Candidates
Asimov Launches RNA Edge, a Lab-in-the-Loop Platform for AI Optimization of RNA Therapeutic Candidates
March 19, 2026
Blog
announcement
science & technology
Asimov Announces Cell Line Development Partnership with Score Pharma to Advance Biosuperior Antibody Therapeutics
Asimov Announces Cell Line Development Partnership with Score Pharma to Advance Biosuperior Antibody Therapeutics
Asimov Announces Cell Line Development Partnership with Score Pharma to Advance Biosuperior Antibody Therapeutics
March 17, 2026
Blog
announcement
science & technology
Asimov and AGC Biologics Team Up to Provide a Cost-Effective, Simplified, and Secure Manufacturing Approach for Viral Vector Production
Asimov and AGC Biologics Team Up to Provide a Cost-Effective, Simplified, and Secure Manufacturing Approach for Viral Vector Production
Asimov and AGC Biologics Team Up to Provide a Cost-Effective, Simplified, and Secure Manufacturing Approach for Viral Vector Production
January 12, 2026
Blog
announcement
science & technology
Asimov Launches CHO Edge Rapid Pools to Bridge Biologics Discovery and CMC with Predictive Stable Expression
Asimov Launches CHO Edge Rapid Pools to Bridge Biologics Discovery and CMC with Predictive Stable Expression
Asimov Launches CHO Edge Rapid Pools to Bridge Biologics Discovery and CMC with Predictive Stable Expression
December 16, 2025
Blog
announcement
science & technology
Optimizing Bispecific Antibody Expression with Amgen
Optimizing Bispecific Antibody Expression with Amgen
Optimizing Bispecific Antibody Expression with Amgen
December 15, 2025
Blog
announcement
science & technology
Asimov Launches Stable AAV Producer Cell Lines, Setting a New Standard for Viral Vector Manufacturing
Asimov Launches Stable AAV Producer Cell Lines, Setting a New Standard for Viral Vector Manufacturing
Asimov Launches Stable AAV Producer Cell Lines, Setting a New Standard for Viral Vector Manufacturing
October 6, 2025
Blog
announcement
science & technology
Forbes
Drug Manufacture Has One Huge Flaw. This Synthetic Biology Startup Just Raised $200m To Fix It.
Drug Manufacture Has One Huge Flaw. This Synthetic Biology Startup Just Raised $200m To Fix It.
January 5, 2023
Blog
announcement
science & technology
STEX25
MIT Startup Exchange Names Asimov to STEX25
MIT Startup Exchange Names Asimov to STEX25
March 19, 2019
Blog
announcement
science & technology
MitAlumni
MIT Spinout Asimov Implements Programming Language for Cells
MIT Spinout Asimov Implements Programming Language for Cells
February 11, 2019
Blog
announcement
science & technology
Discovery Magazine
How Programmable DNA Strands Could Control Healing
How Programmable DNA Strands Could Control Healing
January 2, 2019
Blog
announcement
science & technology
Nature.com
The automatic-design tools that are changing synthetic biology
The automatic-design tools that are changing synthetic biology
December 10, 2018
Blog
announcement
science & technology
MIT Technology Review
Biologists would love to program cells as if they were computer chips
Biologists would love to program cells as if they were computer chips
February 13, 2018
Blog
announcement
science & technology
The Business Journals
How Cambridge Startup Asimov Is Doing Business With 'Genetic Circuits'
How Cambridge Startup Asimov Is Doing Business With 'Genetic Circuits'
January 15, 2018
Blog
announcement
science & technology
TechCrunch
Bio-programming toolkit maker Asimov launches with $4.7M from Andreessen Horowitz
Bio-programming toolkit maker Asimov launches with $4.7M from Andreessen Horowitz
December 19, 2017
Blog
announcement
science & technology
Xconomy
Andreessen Horowitz Backs Asimov’s Synthetic Biology CAD Software
Andreessen Horowitz Backs Asimov’s Synthetic Biology CAD Software
December 19, 2017
Blog
announcement
science & technology
The Business Journals
Andreessen Horowitz leads seed round in MIT-born 'genetic circuits' startup
Andreessen Horowitz leads seed round in MIT-born 'genetic circuits' startup
December 19, 2017
Blog
announcement
science & technology
Medium
Genetic Circuits Startup Asimov Raises Seed Round Led by Andreessen Horowitz
Genetic Circuits Startup Asimov Raises Seed Round Led by Andreessen Horowitz
December 18, 2017
No items found.
Blog
announcement
science & technology
Asimov Announces Cell Line Development Partnership with Kaigene to Advance Multispecific Antibody for Autoimmune Disease
Asimov Announces Cell Line Development Partnership with Kaigene to Advance Multispecific Antibody for Autoimmune Disease
Asimov Announces Cell Line Development Partnership with Kaigene to Advance Multispecific Antibody for Autoimmune Disease
August 18, 2026
Blog
announcement
science & technology
Kyungdong Pharmaceutical and Asimov Announce Completion of Cell Line Development Campaign for Biosimilar Antibody
Kyungdong Pharmaceutical and Asimov Announce Completion of Cell Line Development Campaign for Biosimilar Antibody
Kyungdong Pharmaceutical and Asimov Announce Completion of Cell Line Development Campaign for Biosimilar Antibody
August 9, 2026
Blog
announcement
science & technology
Asimov Joins the Genesis Mission, Using Boston University's NSF-Backed Cloud Lab to Power Lab-in-the-Loop AI Models
Asimov Joins the Genesis Mission, Using Boston University's NSF-Backed Cloud Lab to Power Lab-in-the-Loop AI Models
Asimov Joins the Genesis Mission, Using Boston University's NSF-Backed Cloud Lab to Power Lab-in-the-Loop AI Models
July 24, 2026
Blog
announcement
science & technology
Asimov Launches Chrysalis Transposase, a Wholly-Owned Genome Integration Tool for Biotherapeutics Production
Asimov Launches Chrysalis Transposase, a Wholly-Owned Genome Integration Tool for Biotherapeutics Production
Asimov Launches Chrysalis Transposase, a Wholly-Owned Genome Integration Tool for Biotherapeutics Production
June 23, 2026
Blog
announcement
science & technology
Asimov Announces Strategic Partnership with the Rosalind & Morris Goodman Cancer Institute at McGill University to Advance Next-Generation Biologics
Asimov Announces Strategic Partnership with the Rosalind & Morris Goodman Cancer Institute at McGill University to Advance Next-Generation Biologics
Asimov Announces Strategic Partnership with the Rosalind & Morris Goodman Cancer Institute at McGill University to Advance Next-Generation Biologics
June 18, 2026
Blog
announcement
science & technology
Asimov Completes Lead Optimization Campaign with Mabylon AG to Advance Trispecific Antibody for Tree Pollen Allergies
Asimov Completes Lead Optimization Campaign with Mabylon AG to Advance Trispecific Antibody for Tree Pollen Allergies
Asimov Completes Lead Optimization Campaign with Mabylon AG to Advance Trispecific Antibody for Tree Pollen Allergies
May 7, 2026
Blog
announcement
science & technology
Asimov Launches RNA Edge, a Lab-in-the-Loop Platform for AI Optimization of RNA Therapeutic Candidates
Asimov Launches RNA Edge, a Lab-in-the-Loop Platform for AI Optimization of RNA Therapeutic Candidates
Asimov Launches RNA Edge, a Lab-in-the-Loop Platform for AI Optimization of RNA Therapeutic Candidates
March 19, 2026
Blog
announcement
science & technology
Asimov Announces Cell Line Development Partnership with Score Pharma to Advance Biosuperior Antibody Therapeutics
Asimov Announces Cell Line Development Partnership with Score Pharma to Advance Biosuperior Antibody Therapeutics
Asimov Announces Cell Line Development Partnership with Score Pharma to Advance Biosuperior Antibody Therapeutics
March 17, 2026
Blog
announcement
science & technology
Asimov and AGC Biologics Team Up to Provide a Cost-Effective, Simplified, and Secure Manufacturing Approach for Viral Vector Production
Asimov and AGC Biologics Team Up to Provide a Cost-Effective, Simplified, and Secure Manufacturing Approach for Viral Vector Production
Asimov and AGC Biologics Team Up to Provide a Cost-Effective, Simplified, and Secure Manufacturing Approach for Viral Vector Production
January 12, 2026
Blog
announcement
science & technology
Asimov Launches CHO Edge Rapid Pools to Bridge Biologics Discovery and CMC with Predictive Stable Expression
Asimov Launches CHO Edge Rapid Pools to Bridge Biologics Discovery and CMC with Predictive Stable Expression
Asimov Launches CHO Edge Rapid Pools to Bridge Biologics Discovery and CMC with Predictive Stable Expression
December 16, 2025
Blog
announcement
science & technology
Optimizing Bispecific Antibody Expression with Amgen
Optimizing Bispecific Antibody Expression with Amgen
Optimizing Bispecific Antibody Expression with Amgen
December 15, 2025
Blog
announcement
science & technology
Asimov Launches Stable AAV Producer Cell Lines, Setting a New Standard for Viral Vector Manufacturing
Asimov Launches Stable AAV Producer Cell Lines, Setting a New Standard for Viral Vector Manufacturing
Asimov Launches Stable AAV Producer Cell Lines, Setting a New Standard for Viral Vector Manufacturing
October 6, 2025
No items found.
Learn about biology through the eyes of our founders
Synthetic Biology: Programming Living Bacteria
Christopher Voigt
The Future Will Be Genetically Engineered
Alec Nielsen
